Financhill
Buy
60

STE Quote, Financials, Valuation and Earnings

Last price:
$231.49
Seasonality move :
2.68%
Day range:
$228.34 - $234.50
52-week range:
$197.82 - $248.24
Dividend yield:
0.96%
P/E ratio:
49.41x
P/S ratio:
4.28x
P/B ratio:
3.56x
Volume:
667.4K
Avg. volume:
540.1K
1-year change:
-0.12%
Market cap:
$22.9B
Revenue:
$5.1B
EPS (TTM):
$4.71

Analysts' Opinion

  • Consensus Rating
    Steris PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $250.13, Steris PLC has an estimated upside of 7.47% from its current price of $232.74.
  • Price Target Downside
    According to analysts, the lowest downside price target is $230.00 representing 1.18% downside risk from its current price of $232.74.

Fair Value

  • According to the consensus of 6 analysts, Steris PLC has 7.47% upside to fair value with a price target of $250.13 per share.

STE vs. S&P 500

  • Over the past 5 trading days, Steris PLC has overperformed the S&P 500 by 9.54% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Steris PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Steris PLC has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Steris PLC reported revenues of $1.4B.

Earnings Growth

  • Steris PLC has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Steris PLC reported earnings per share of $1.75.
Enterprise value:
24.9B
EV / Invested capital:
2.90x
Price / LTM sales:
4.28x
EV / EBIT:
27.82x
EV / Revenue:
4.61x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
33.12x
Price / Operating cash flow:
30.74x
Enterprise value / EBITDA:
18.00x
Gross Profit (TTM):
$2.3B
Return On Assets:
4.42%
Net Income Margin (TTM):
8.66%
Return On Equity:
7.27%
Return On Invested Capital:
5.15%
Operating Margin:
18.06%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $4.4B $4.7B $5.4B $1.3B $1.4B
Gross Profit $2B $2B $2.3B $560M $610.3M
Operating Income $677.6M $873.9M $927.6M $226.5M $247.5M
EBITDA $832.7M $1.9B $1.4B $369.2M $373.8M
Diluted EPS -$0.29 $5.71 $4.71 $1.42 $1.75
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $1.2B $1.9B $2B $2.2B $1.9B
Total Assets $6.6B $11.7B $10.8B $11.4B $10B
Current Liabilities $505.9M $904.3M $796.5M $913.7M $891.1M
Total Liabilities $2.7B $5.1B $4.8B $5B $3.6B
Total Equity $3.9B $6.6B $6B $6.4B $6.4B
Total Debt $1.7B $3.3B $3.1B $3.3B $2.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $712.9M $934.3M $1.1B $291.2M $332.8M
Cash From Investing -$212.2M -$869.3M $363M -$118.9M -$123.9M
Cash From Financing -$581.4M -$133.4M -$1.5B -$198M -$214.4M
Free Cash Flow $349.3M $594M $751.4M $172.3M $243.6M
STE
Sector
Market Cap
$22.9B
$38.8M
Price % of 52-Week High
93.76%
46.15%
Dividend Yield
0.96%
0%
Shareholder Yield
3.37%
-0.74%
1-Year Price Total Return
-0.12%
-38.9%
Beta (5-Year)
0.919
0.773
Dividend yield:
0.96%
Annualized payout:
$2.03
Payout ratio:
46.04%
Growth streak:
13 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $225.42
200-day SMA
Buy
Level $224.37
Bollinger Bands (100)
Buy
Level 210.9 - 225.08
Chaikin Money Flow
Buy
Level 143.4M
20-day SMA
Buy
Level $223.18
Relative Strength Index (RSI14)
Buy
Level 71.38
ADX Line
Buy
Level 18.42
Williams %R
Sell
Level -8.9385
50-day SMA
Buy
Level $216.45
MACD (12, 26)
Buy
Level 3.12
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Neutral
Level 113.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.0006)
Buy
CA Score (Annual)
Level (0.3693)
Buy
Beneish M-Score (Annual)
Level (-2.682)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.9054)
Buy
Piotroski F Score (Annual)
Level (7)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Stock Forecast FAQ

In the current month, STE has received 2 Buy ratings 4 Hold ratings, and 0 Sell ratings. The STE average analyst price target in the past 3 months is $250.13.

  • Where Will Steris PLC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Steris PLC share price will rise to $250.13 per share over the next 12 months.

  • What Do Analysts Say About Steris PLC?

    Analysts are divided on their view about Steris PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Steris PLC is a Sell and believe this share price will drop from its current level to $230.00.

  • What Is Steris PLC's Price Target?

    The price target for Steris PLC over the next 1-year time period is forecast to be $250.13 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is STE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Steris PLC is a Hold. 4 of 6 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of STE?

    You can purchase shares of Steris PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Steris PLC shares.

  • What Is The Steris PLC Share Price Today?

    Steris PLC was last trading at $231.49 per share. This represents the most recent stock quote for Steris PLC. Yesterday, Steris PLC closed at $232.74 per share.

  • How To Buy Steris PLC Stock Online?

    In order to purchase Steris PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

IBM Stock: Stable Dividend or Stagnant Investment?
IBM Stock: Stable Dividend or Stagnant Investment?

The AI race has heated up significantly but returns on…

Is Trimble Stock a Buy, Sell or Hold?
Is Trimble Stock a Buy, Sell or Hold?

Trimble (NASDAQ:TRMB) is a hardware and software tech company that…

Is DraftKings Stock a Good Bet on the Future of Sports Betting?
Is DraftKings Stock a Good Bet on the Future of Sports Betting?

It seems like right now is a good time to…

Stock Ideas

Buy
62
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 36x

Alerts

Buy
86
WLDN alert for Mar 10

Willdan Group [WLDN] is down 3.66% over the past day.

Buy
76
PDEX alert for Mar 10

Pro-Dex [PDEX] is up 10.33% over the past day.

Sell
7
IOT alert for Mar 10

Samsara [IOT] is down 3.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock